What is PLSE's current stock price?

PLSE (Pulse Biosciences, Inc.) is currently trading at $25.89 with a market cap of $1.79B.

What sector is Pulse Biosciences, Inc. in?

Pulse Biosciences, Inc. (PLSE) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.

Is PLSE a good stock to buy?

Analysts have a Buy consensus on PLSE with a price target of $30.00. Check our detailed analysis for valuation, financials, and insider activity.

InvestLog

PLSE Pulse Biosciences, Inc.

Healthcare

$25.89+1.29%ClosedMarket Cap: $1.79B

As of 2026-05-25

Valuation

View Details

P/E (TTM)

—

PEG

—

P/B

26.47

P/S

2385.94

EV/EBITDA

-23.46

DCF Value

$1.06

FCF Yield

-3.1%

Div Yield

0.0%

Margins & Returns

Gross Margin

-91.1%

Operating Margin

-10392.1%

Net Margin

-9929.0%

ROE

-86.7%

ROA

-91.4%

ROIC

-106.3%

Financials

View All

Period	Revenue	Net Income	EPS
Q1 null	$401.0K	$-18.6M	$—
Q4 null	$264.0K	$-17.4M	$—
FY null	$350.0K	$-72.8M	$—
Q3 null	$86.0K	$-19.4M	$—

Analyst Ratings

View All

Consensus

Buy

Target (Consensus)

$30.00

Target (Median)

$30.00

Target Range

$30.00 - $30.00

0 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell

Trading Activity

Insider Trades

View All

DUGGAN ROBERT Wdirector, 10 percent owner:

BuyFri May 15

LAVIOLETTE PAUL Adirector, officer: Chief Executive Officer

BuyMon May 11

DUGGAN ROBERT Wdirector, 10 percent owner:

BuyMon May 11

UECKER DARRINdirector, officer: Chief Technology Officer

SellFri Apr 03

Danahy Kevin Patrickofficer: Chief Commercial Officer

SellMon Feb 23

Related AI Research

Insider BuyMay 12, 2026

Duggan Robert W buys $13.0M of PLSE

Robert W.

Company Info

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Country

Exchange

—

Beta

1.63

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

Peers

OPK